drug
as of 2026-07-01NST-SPARK
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by North Shore Therapeutics, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Investigational (via trials)
Trials
1
NST-SPARK Open-Label Phase 1 STTR (IGNITE)
NCT07593456—Not Yet Recruiting
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
KOL
Moein Foroughi, MD
personKOL score —
Dan Wolf, MD
personKOL score —
Christian Kohler, MD
personKOL score —